| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-06 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-06 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-06 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.15 | 8e-06 |